INOVIO Pharma Reports International Vaccine Institute, Coalition for Epidemic Preparedness Innovations Granted $6.9M Funding To Co. To work For Phase 1/2 Trial Of Co.'s INO-4800 Coronavirus Vaccine Candidate In South Korea